JP2025501411A5 - - Google Patents

Info

Publication number
JP2025501411A5
JP2025501411A5 JP2024561731A JP2024561731A JP2025501411A5 JP 2025501411 A5 JP2025501411 A5 JP 2025501411A5 JP 2024561731 A JP2024561731 A JP 2024561731A JP 2024561731 A JP2024561731 A JP 2024561731A JP 2025501411 A5 JP2025501411 A5 JP 2025501411A5
Authority
JP
Japan
Prior art keywords
disorder
compound
pharmaceutical composition
depression
free form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024561731A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025501411A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/010055 external-priority patent/WO2023130119A1/en
Publication of JP2025501411A publication Critical patent/JP2025501411A/ja
Publication of JP2025501411A5 publication Critical patent/JP2025501411A5/ja
Pending legal-status Critical Current

Links

JP2024561731A 2022-01-03 2023-01-03 重水素化有機化合物およびその使用 Pending JP2025501411A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US202263296137P 2022-01-03 2022-01-03
US63/296,137 2022-01-03
US202263314466P 2022-02-27 2022-02-27
US63/314,466 2022-02-27
US202263345002P 2022-05-23 2022-05-23
US63/345,002 2022-05-23
US202263394565P 2022-08-02 2022-08-02
US63/394,565 2022-08-02
US202263384988P 2022-11-25 2022-11-25
US63/384,988 2022-11-25
PCT/US2023/010055 WO2023130119A1 (en) 2022-01-03 2023-01-03 Deuterated organic compounds and uses thereof

Publications (2)

Publication Number Publication Date
JP2025501411A JP2025501411A (ja) 2025-01-17
JP2025501411A5 true JP2025501411A5 (cg-RX-API-DMAC10.html) 2026-05-13

Family

ID=87000385

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024561731A Pending JP2025501411A (ja) 2022-01-03 2023-01-03 重水素化有機化合物およびその使用

Country Status (10)

Country Link
US (1) US12606523B2 (cg-RX-API-DMAC10.html)
EP (1) EP4460292A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025501411A (cg-RX-API-DMAC10.html)
KR (1) KR20240132477A (cg-RX-API-DMAC10.html)
AU (1) AU2023204433B2 (cg-RX-API-DMAC10.html)
CA (1) CA3242755A1 (cg-RX-API-DMAC10.html)
IL (1) IL313999A (cg-RX-API-DMAC10.html)
MX (1) MX2024008371A (cg-RX-API-DMAC10.html)
TW (1) TW202333671A (cg-RX-API-DMAC10.html)
WO (1) WO2023130119A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025010255A2 (en) 2023-07-02 2025-01-09 Engrail Therapeutics, Inc. Deuterated organic compounds and uses thereof
WO2026011157A1 (en) 2024-07-05 2026-01-08 Engrail Therapeutics, Inc. Crystalline forms

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197243A (en) * 1975-04-02 1980-04-08 Yamanouchi Pharmaceutical Co., Ltd. N-1-Benzyl-3-pyrrolidinyl-4-dimethylamino benzamide derivatives
US4210660A (en) 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
TW212139B (cg-RX-API-DMAC10.html) 1991-04-15 1993-09-01 Yamanouchi Pharma Co Ltd
KR100355130B1 (ko) 1992-09-18 2003-01-30 야마노우치세이야쿠 가부시키가이샤 하이드로겔서방성정제
US5705498A (en) 1992-11-05 1998-01-06 Smithkline Beecham Plc. Piperidine derivatives as 5-HT4 receptor antagonists
US6872405B2 (en) 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
KR102967223B1 (ko) 2013-12-03 2026-05-19 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
CN104744333A (zh) 2013-12-26 2015-07-01 张云 一种奈莫必利的生产方法
US20190343827A1 (en) 2018-05-08 2019-11-14 Izumi Technology, Llc Deuterated analogs of tariquidar
WO2020176597A1 (en) 2019-02-27 2020-09-03 The Regents Of The University Of California N-substituted indoles and other heterocycles for treating brain disorders
US20210017160A1 (en) 2019-07-16 2021-01-21 Cyclerion Therapeutics, Inc. DEUTERATED sGC STIMULATORS
JP2025501410A (ja) 2022-01-03 2025-01-17 エングレイル・セラピューティクス・インコーポレイテッド 重水素化有機化合物およびその使用
WO2025010255A2 (en) 2023-07-02 2025-01-09 Engrail Therapeutics, Inc. Deuterated organic compounds and uses thereof

Similar Documents

Publication Publication Date Title
KR102457146B1 (ko) Shp2의 활성을 억제하기 위한 화합물 및 조성물
JP2009538853A5 (cg-RX-API-DMAC10.html)
JP2023527575A5 (cg-RX-API-DMAC10.html)
RU2015143466A (ru) Нейроактивные стероиды и способы их применения
AU2016228207B2 (en) Sigma ligands for the prevention or treatment of pain induced by chemotherapy
JP2018070614A5 (cg-RX-API-DMAC10.html)
RU2009136330A (ru) Тетрагидроизохинолиновые соединения в качестве модуляторов гистаминового н3 рецептора
CN118576586A (zh) 治疗神经和精神疾病的方法
RU2009103307A (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ
JP2022515766A5 (cg-RX-API-DMAC10.html)
JP2022549335A5 (cg-RX-API-DMAC10.html)
RU2002119417A (ru) Новые модуляторы дофаминовой нейротрансмиссии
JP2009527462A5 (cg-RX-API-DMAC10.html)
JP2019534327A5 (cg-RX-API-DMAC10.html)
JP2020511515A5 (cg-RX-API-DMAC10.html)
KR20180080305A (ko) 인돌린-2-온 유도체
CN104725249A (zh) 苄胺类衍生物及其在药物上的应用
RU2006124863A (ru) Трициклические производные индолгидроксиэтиламина и их применение при лечении болезни альцгеймера
JP2022513933A5 (cg-RX-API-DMAC10.html)
RU2008148941A (ru) 4-[(3-фторфенокси)фенилметил]пиперидин метансульфонат, применение, способ синтеза и фармацевтические композиции
US20180244623A1 (en) N-methyl-D-aspartate Receptor (NMDAR) Potentiators, Pharmaceutical Compositions, And Uses Related Thereto
TWI677495B (zh) 吲哚啉-2-酮衍生物
JP2024511057A5 (cg-RX-API-DMAC10.html)
ES2388253B1 (es) Ligandos sigma para la prevención o el tratamiento de dolor inducido por quimioterapia
JP2024517789A5 (cg-RX-API-DMAC10.html)